Arcutis Biotherapeutics, Inc. 10-Q filing
Filed 2026-05-06 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001787306-26-000040
- Form type
- 10-Q
- CIK
- 0001787306
- Primary document
- https://www.sec.gov/Archives/edgar/data/1787306/000178730626000040/arqt-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Arcutis Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $105.4M | - | - |
| Cost Of Revenue | $9.8M | - | - |
| Operating Income | $-9.1M | - | - |
| Net Income | $-11.3M | - | - |
| Eps Basic | -0.09 | - | - |
| Eps Diluted | -0.09 | - | - |
| Cash And Equivalents | $34.8M | - | - |
| Total Assets | $460.0M | - | - |
| Total Liabilities | $270.4M | - | - |
| Shareholders Equity | $189.6M | - | - |
| Operating Cash Flow | $2.2M | - | - |
| Capital Expenditures | $0 | - | - |